
To describe and assess the response to short-term zzso as shown by zzso and clinical variables in patients with zzso zzso zzso selected for eligibility for zzso necrosis factor zzso 

In a zzso zzso study, 22 patients with AS and eligible for biological therapy were treated with 90 zzso of zzso zzso Clinical and laboratory parameters were obtained and zzso of the zzso zzso and the lower zzso and zzso spine performed at baseline and at week zzso The primary end point was the proportion of patients fulfilling the zzso international Society zzso response criteria for biological therapies zzso while secondary end points included the change in zzso bone zzso 

Eight of 20 zzso improved enough to meet the zzso response criteria and most clinical variables improved zzso Fifteen patients had a total of 63 zzso zzso overall, zzso zzso with paired scans either resolved completely or improved, while five zzso worsened or appeared during zzso 

zzso is an effective symptomatic treatment for patients with zzso however, its effect on zzso zzso is zzso Further studies are needed to determine the effect of zzso on zzso bone zzso 

